A novel KCNC1 gain‐of‐function variant causing developmental and epileptic encephalopathy: “Precision medicine” approach with fluoxetine
Authors:
Abstract
Variable phenotypes, including developmental encephalopathy with (DEE) or without seizures and myoclonic epilepsy and ataxia due to potassium channel mutation, are caused by pathogenetic variants in KCNC1, encoding for Kv3.1 channel subunits. In vitro, channels carrying most KCNC1 pathogenic variants display loss‐of‐function features. Here, we describe a child affected by DEE with fever‐triggered seizures, caused by a novel de novo heterozygous missense KCNC1 variant (c.1273G>A; V425M). Patch‐clamp recordings in transiently transfected CHO cells revealed that, compared to wild‐type, Kv3.1 V425M currents (1) were larger, with membrane potentials between −40 and +40 mV; (2) displayed a hyperpolarizing shift in activation gating; (3) failed to inactivate; and (4) had slower activation and deactivation kinetics, consistent with a mixed functional pattern with prevalent gain‐of‐function effects. Exposure to the antidepressant drug fluoxetine inhibited currents expressed by both wild‐type and mutant Kv3.1 channels. Treatment of the proband with fluoxetine led to a rapid and prolonged clinical amelioration, with the disappearance of seizures and an improvement in balance, gross motor skills, and oculomotor coordination. These results suggest that drug repurposing based on the specific genetic defect may provide an effective personalized treatment for KCNC1‐related DEEs.Keywords
Funding Information
- Ministero della Salute (GR‐2016‐02363337, RF‐2019‐12370491)
- Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN 2017ALCR7C)
This publication has 19 references indexed in Scilit:
- Myoclonus epilepsy and ataxia due to KCNC1 mutation: Analysis of 20 cases and K+ channel propertiesAnnals of Neurology, 2017
- Loss of Function of KCNC1 is associated with intellectual disability without seizuresEuropean Journal of Human Genetics, 2017
- Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK) is caused by heterozygous KCNC1 mutationsEpileptic Disorders, 2016
- A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsyNature Genetics, 2014
- Hydrogen bonds as molecular timers for slow inactivation in voltage-gated potassium channelseLife, 2013
- Open Channel Block of Kv3.1 Currents by FluoxetineJournal of Pharmacological Sciences, 2008
- MinK, MiRP1, and MiRP2 Diversify Kv3.1 and Kv3.2 Potassium Channel GatingJournal of Biological Chemistry, 2004
- Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3.1Neuropharmacology, 2001
- Brain Pharmacokinetics and Tissue Distribution In Vivo of Fluvoxamine and Fluoxetine by Fluorine Magnetic Resonance SpectroscopyNeuropsychopharmacology, 2000
- Contributions of Kv3 Channels to Neuronal ExcitabilityAnnals of the New York Academy of Sciences, 1999